• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immunome, Inc. - Common Stock (NQ:IMNM)

22.41 -0.44 (-1.93%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 08, 2026
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Announces Pricing of Public Offering of Common Stock
December 16, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
December 16, 2025
Issued on behalf of Oncolytics Biotech Inc. 
From Equity Insider
Via GlobeNewswire
News headline image
Immunome Announces Proposed Public Offering of Common Stock
December 15, 2025
From Immunome, Inc.
Via Business Wire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy
December 15, 2025
Via AB Newswire
News headline image
Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
December 15, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
December 14, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at Upcoming Investor Conferences
November 25, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
November 06, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 04, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
October 31, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance
October 23, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Infinimmune Announces Research Collaboration with Immunome
September 18, 2025
From Infinimmune
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update
August 06, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at Upcoming Investor Conferences
May 22, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference
April 04, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Full Year 2024 Financial Results and Provides Business Update
March 19, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC
March 10, 2025
From Immunome, Inc.
Via Business Wire
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2025
From Immunome, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap